Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lijian Feng

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
World Journal of Microbiology & Biotechnology|July 18, 2013
Responses of antioxidant defenses and membrane damage to drought stress in fruit bodies of Auricularia auricula-judaeHuailiang Ma, Xiuhong Xu, Lijian Feng
Analytical Biochemistry|January 24, 2017
Split luciferase-based biosensors for characterizing EED bindersLing Li, Lijian Feng, Minlong Shi, et al.
Journal of Medicinal Chemistry|January 3, 2024
Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection ApproachShaozhao Qin, Lijian Feng, Qingyi Zhao, et al.
Plos One|January 11, 2017
Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EEDLing Li, Hailong Zhang, Man Zhang, et al.
Cell Research|August 5, 2024
SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinomaBisi Miao, Ling Ge, Chenxi He, et al.
Journal of Medicinal Chemistry|January 17, 2017
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer EfficacyYing Huang, Jeff Zhang, Zhengtian Yu, et al.
Nature Chemical Biology|January 31, 2017
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EEDWei Qi, Kehao Zhao, Justin Gu, et al.
Journal of Medicinal Chemistry|March 30, 2022
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced MalignanciesYing Huang, Martin Sendzik, Jeff Zhang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
World Journal of Microbiology & Biotechnology|July 18, 2013
Responses of antioxidant defenses and membrane damage to drought stress in fruit bodies of Auricularia auricula-judaeHuailiang Ma, Xiuhong Xu, Lijian Feng
Analytical Biochemistry|January 24, 2017
Split luciferase-based biosensors for characterizing EED bindersLing Li, Lijian Feng, Minlong Shi, et al.
Journal of Medicinal Chemistry|January 3, 2024
Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection ApproachShaozhao Qin, Lijian Feng, Qingyi Zhao, et al.
Plos One|January 11, 2017
Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EEDLing Li, Hailong Zhang, Man Zhang, et al.
Cell Research|August 5, 2024
SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinomaBisi Miao, Ling Ge, Chenxi He, et al.
Journal of Medicinal Chemistry|January 17, 2017
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer EfficacyYing Huang, Jeff Zhang, Zhengtian Yu, et al.
Nature Chemical Biology|January 31, 2017
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EEDWei Qi, Kehao Zhao, Justin Gu, et al.
Journal of Medicinal Chemistry|March 30, 2022
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced MalignanciesYing Huang, Martin Sendzik, Jeff Zhang, et al.
Pageof 1